search icon

    Market Snapshot

    • S&P Futures

      3,809.5

    • Dow Futures

      30,868

    • Nasdaq Futures

      11,633.25

    blog search icon

    Biohaven Pharmaceutical Holding Company Ltd.

    (NYSE:BHVN)

    $145.71

    $0.06

    0.04%

    Biohaven Pharmaceutical Holding Company Ltd. Chart

    BHVN Stock Price Today

    Biohaven Pharmaceutical Holding Company Ltd. (BHVN) stock rallied over 0.04% intraday to trade at $145.71 a share on NYSE. The stock opened with a loss of -0.54% at $145.61 and touched an intraday high of $146, rising 0.04% against the last close of $145.65. The stock went to a low of $145.6 during the session.

    Stock Snapshot

    $145.65

    Prev. Close

    10.38 Billion

    Market Cap

    $145.6

    Day Low

    $145.61

    Open

    70.33 Million

    Number of Shares

    $146

    Day High

    -

    P/E ratio

    -11.85

    EPS (TTM)

    5.17

    Cash Flow per Share

    6.57

    Free Float in %

    -8.98

    Book Value

    902,454

    Volume

    Biohaven Pharmaceutical Holding Company Ltd. Historical Data

    DateOpenHighLowCloseVolume
    2022-06-30$145.61$146$145.6$145.71892,673
    2022-06-29$146.5$146.59$145.65$145.651,790,700
    2022-06-28$144.35$145.49$143.7$144.42856,200
    2022-06-27$144.35$144.72$143.18$144.011,024,000
    2022-06-24$144.7$145$143.79$143.791,858,900
    2022-06-23$144.71$145$144.04$144.21,007,900
    2022-06-22$145$145.41$144.5$144.56669,400
    2022-06-21$145.75$146$144.62$145725,800
    2022-06-17$145$146.19$144.43$145.141,446,900
    2022-06-16$144.35$145.2$144.05$145450,500

    Contact Details

    215 Church Street
    New Haven, CT 06510
    United States

    Webiste:BHVN

    203 404 0410

    Company Information

    Employees-

    Beta1.11

    Sales or Revenue462.51 Million

    5Y Sales Change-

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryBiotechnology

    About Company

    Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavegepant that is in phase III clinical trials for acute and preventive treatment of migraine, as well as respiratory complications and non-migraine studies; and BHV-3100 for non-migraine indications. The company also offers Troriluzole for spinocerebellar ataxia and obsessive compulsive disorders, as well as Alzheimer diseases; BHV-0223, a product for amyotrophic lateral sclerosis; BHV-5000/5500 for neuropsychiatric indications; and Verdiperstat, a product for multiple system atrophy and amyotrophic lateral sclerosis. Biohaven Pharmaceutical Holding Company Ltd. has a collaboration agreement with Cove to facilitate telemedicine evaluation for migraine sufferers. The company was incorporated in 2013 and is headquartered in New Haven, Connecticut.

    Frequently Asked Questions

    icon

    What is the current Biohaven Pharmaceutical Holding Company Ltd. (BHVN) stock price?

    Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) stock price is $145.71 as of the last check on Thursday, June 30. During the trading session, BHVN stock reached the peak price of $146 while $145.6 was the lowest point it dropped to.

    icon

    BHVN's industry and sector of operation?

    The NYSE listed BHVN is part of Biotechnology industry that operates in the broader Health Care sector. Biohaven Pharmaceutical Holding Company Ltd. , a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States.

    icon

    Who are the executives of BHVN?

    Dr. Vladimir Coric M.D.
    Chairman, CEO & Pres
    Mr. Matthew Buten
    Chief Financial Officer
    Ms. Kimberly Gentile
    Sr. VP of Clinical Operations
    Dr. Elyse Stock M.D.
    Chief Medical Officer

    icon

    What is the BHVN stock price today?

    BHVN stock traded closed the last session at $145.71, which is $0.06 or 0.04% lower than its previous close of $145.65. BHVN's current trading price is 84.42% lower than its 52-week high of $151.51 where as its distance from 52-week low of 79.01% is -3.83%.

    icon

    How many employees does BHVN have?

    Number of BHVN employees currently stands at -. BHVN operates from 215 Church Street, New Haven, CT 06510, United States.

    icon

    Link for BHVN official website?

    Official Webiste of $BHVN is: https://www.biohavenpharma.com

    icon

    How do I contact BHVN?

    BHVN could be contacted at BHVN operates from 215 Church Street, New Haven, CT 06510, United States, or at phone #203 404 0410 and can also be accessed through its website.

    icon

    How many shares of BHVN are traded daily?

    BHVN stock volume for the day was 902,454 shares while in the previous session number of BHVN shares traded was 892,673 . The average number of BHVN shares traded daily for last 3 months was 1.77 Million.

    icon

    How much did BHVN change today?

    The percentage change in BHVN stock occurred in the recent session was 0.04% while the dollar amount for the price change in BHVN stock was $0.06.

    icon

    What price range BHVN stock been trading in?

    In the recent session, the day high for BHVN stock was $146 while the low for BHVN stock touched on the day was $145.6.

    icon

    What is the market cap of BHVN currently?

    The market value of BHVN currently stands at 10.38 Billion with its latest stock price at $145.71 and 70.33 Million of its shares outstanding.